Literature DB >> 3367175

Development of a Crohn's index for survey research.

R S Sandler1, M C Jordan, L L Kupper.   

Abstract

Current Crohn's disease activity indices are not suitable for survey research because they rely on information from the laboratory or physical examination. We used data from a multicenter controlled trial of adjuvant sulfasalazine to develop an index of Crohn's disease activity based on information which could be obtained exclusively by interview. The study population consisted of 89 actively symptomatic patients seen on 1082 occasions in eight medical centers. Multiple regression analyses identified three variables which predicted the ratings of physicians: stool frequency, abdominal pain and sense of well-being. The new index correlated very well (r = 0.87, p less than 0.001) with the Crohn's Disease Activity Index from which it was derived. The index may be used in epidemiologic studies to accurately place patients into quartiles of disease severity which correspond to similar quartiles of the CDAI.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3367175     DOI: 10.1016/0895-4356(88)90046-7

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  12 in total

Review 1.  Assessing disease activity and disease activity indices for inflammatory bowel disease.

Authors:  Feng Xiao Li; Lloyd R Sutherland
Journal:  Curr Gastroenterol Rep       Date:  2002-12

2.  Use of the Crohn's disease activity index in clinical trials of biological agents.

Authors:  Hugh-J Freeman
Journal:  World J Gastroenterol       Date:  2008-07-14       Impact factor: 5.742

Review 3.  Impact of antibodies to infliximab on clinical outcomes and serum infliximab levels in patients with inflammatory bowel disease (IBD): a meta-analysis.

Authors:  Kavinderjit S Nanda; Adam S Cheifetz; Alan C Moss
Journal:  Am J Gastroenterol       Date:  2012-11-13       Impact factor: 10.864

4.  Racial disparities in utilization of specialist care and medications in inflammatory bowel disease.

Authors:  Geoffrey C Nguyen; Thomas A LaVeist; Mary L Harris; Ming-Hsi Wang; Lisa W Datta; Steven R Brant
Journal:  Am J Gastroenterol       Date:  2010-05-18       Impact factor: 10.864

5.  Sexual Dysfunction in Men With Inflammatory Bowel Disease: A New IBD-Specific Scale.

Authors:  Aoibhlinn O'Toole; Punyanganie S de Silva; Linda G Marc; Christine A Ulysse; Marcia A Testa; Amanda Ting; Alan Moss; Josh Korzenik; Sonia Friedman
Journal:  Inflamm Bowel Dis       Date:  2018-01-18       Impact factor: 5.325

6.  Short pediatric Crohn's disease activity index for quality improvement and observational research.

Authors:  Michael D Kappelman; Wallace V Crandall; Richard B Colletti; Anthony Goudie; Ian H Leibowitz; Lynn Duffy; David E Milov; Sandra C Kim; Bess T Schoen; Ashish S Patel; John Grunow; Evette Larry; Gerry Fairbrother; Peter Margolis
Journal:  Inflamm Bowel Dis       Date:  2010-09-01       Impact factor: 5.325

7.  Patient trust-in-physician and race are predictors of adherence to medical management in inflammatory bowel disease.

Authors:  Geoffrey C Nguyen; Thomas A LaVeist; Mary L Harris; Lisa W Datta; Theodore M Bayless; Steven R Brant
Journal:  Inflamm Bowel Dis       Date:  2009-08       Impact factor: 5.325

8.  Long-term response rates to infliximab therapy for Crohn's disease in an outpatient cohort.

Authors:  Christopher W Teshima; Adrienne Thompson; LeRose Dhanoa; Levinus A Dieleman; Richard N Fedorak
Journal:  Can J Gastroenterol       Date:  2009-05       Impact factor: 3.522

9.  A pilot study examining the relationship among Crohn disease activity, glucagon-like peptide-2 signalling and intestinal function in pediatric patients.

Authors:  David L Sigalet; Dragan Kravarusic; Decker Butzner; Bolette Hartmann; Jens J Holst; Jon Meddings
Journal:  Can J Gastroenterol       Date:  2013-10       Impact factor: 3.522

10.  Health status and health care use in persons with inflammatory bowel disease. A national sample.

Authors:  D A Drossman; J Leserman; C M Mitchell; Z M Li; E A Zagami; D L Patrick
Journal:  Dig Dis Sci       Date:  1991-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.